Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-05 23:50 | 2022-08-03 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP&President-PharmacyServices | Retail-Drug Stores and Proprietary Stores | OPT+S | $98.94 | 143,440 | $14,192,370 | 109,183 | -56.8% |
| 2022-02-03 00:20 | 2022-02-01 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP&President-PharmacyServices | Retail-Drug Stores and Proprietary Stores | OPT+S | $106.50 | 21,386 | $2,277,566 | 61,341 | -25.9% |
| 2021-06-30 00:43 | 2021-06-28 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP&President-PharmacyServices | Retail-Drug Stores and Proprietary Stores | SALE | $83.67 | 2,781 | $232,686 | 61,048 | -4.4% |
| 2021-01-13 01:43 | 2021-01-08 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP and President-CVS Caremark | Retail-Drug Stores and Proprietary Stores | OPT+S | $75.00 | 25,836 | $1,937,700 | 8,369 | -75.5% |
| 2020-11-18 00:22 | 2020-11-13 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP and President-CVS Caremark | Retail-Drug Stores and Proprietary Stores | SALE | $70.00 | 7,138 | $499,660 | 8,023 | -47.1% |
| 2020-05-13 16:08 | 2020-05-11 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP and President-CVS Caremark | Retail-Drug Stores and Proprietary Stores | BUY | $63.14 | 5,000 | $315,675 | 15,161 | +49.2% |
| 2011-05-02 22:23 | 2011-04-28 | MGLN | MAGELLAN HEALTH SERVICES INC | Lotvin Alan | Officer; President, ICore Healthcare | Services-Hospitals | SALE | $52.44 | 1,216 | $63,770 | 733 | -62.4% |
| 2011-04-06 03:39 | 2011-04-04 | MGLN | MAGELLAN HEALTH SERVICES INC | Lotvin Alan | Officer; President, ICore Healthcare | Services-Hospitals | SALE | $49.90 | 7,458 | $372,154 | 849 | -89.8% |
| 2010-11-10 23:32 | 2010-11-08 | MGLN | MAGELLAN HEALTH SERVICES INC | Lotvin Alan | Officer; President, ICore Healthcare | Services-Hospitals | SALE | $48.88 | 10,534 | $514,886 | 209 | -98.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.